Waters Corporation has announced the appointment of Dan Brennan and Mark Vergnano, to its Board of Directors, effective November 23, 2022. Brennan currently serves as Executive Vice President and Chief Financial Officer of Boston Scientific Corporation, a global medical device company, and Vergnano is the former Chairman, President and Chief Executive Officer of The Chemours Company, a chemistry company.

With these appointments, the Board will expand to nine members, eight of whom are independent and five of whom have been appointed in the last five years.

In his current role as Executive Vice President and Chief Financial Officer of Boston Scientific Corporation, Brennan is responsible for several company functions, including global controllership, global internal audit, corporate finance, treasury, corporate tax, investor relations, and corporate business development. Prior to that, he was the company’s Senior Vice President and Corporate Controller and held other roles of increasing responsibility within finance. 

Vergnano currently serves as a Partner at Sea Shell Partners. He previously served as the Chairman, President and Chief Executive Officer of The Chemours Company. Prior to that, he held roles of increasing responsibility at E.I. Dupont De Nemours & Company, culminating in his role as Executive Vice President.